Last news
Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters

Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters

The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2,...

GIGABYTE Opens COMPUTEX 2026 with ENTER INFINITY, Where AI, Gaming, and PC Innovation Unite

GIGABYTE Opens COMPUTEX 2026 with ENTER INFINITY, Where AI, Gaming, and PC Innovation Unite

TAIPEI, June 2, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, today officially opened COMPUTEX 2026 under the theme "ENTER INFINITY," drawing strong visitor engagement across next-generation PC innovation, gaming, and...

IBM Commits More Than $10 Billion to Quantum Computing, Funding Its Roadmap from Today's Leading Systems to the World's First Fault-Tolerant Quantum Computers

IBM Commits More Than $10 Billion to Quantum Computing, Funding Its Roadmap from Today's Leading Systems to the World's First Fault-Tolerant Quantum Computers

Five-year investment spans research and development, manufacturing, M&A and ecosystem expansion as IBM extends its global lead in quantum computing and advances U.S. leadership ARMONK, N.Y., June 2, 2026 /PRNewswire/ -- IBM (NYSE: IBM) has...

SI Group Announces New Board of Directors to Support Next Phase of Growth

SI Group Announces New Board of Directors to Support Next Phase of Growth

Board appointments support SI Group's commitment to delivering customer value and long-term growth THE WOODLANDS, Texas, June 2, 2026 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions,...

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases

Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immune-mediated kidney diseases Civorebrutinib adds pipeline-in-a-product potential across multiple...

Delta Debuts Prefabricated AI Modular Data Center Solution at COMPUTEX 2026 to Reduce Deployment Time by Up to 60%

Delta Debuts Prefabricated AI Modular Data Center Solution at COMPUTEX 2026 to Reduce Deployment Time by Up to 60%

TAIPEI, June 2, 2026 /PRNewswire/ -- Delta, a global leader in power management and smart green solutions, is participating in COMPUTEX 2026 under the theme "Superior Efficiency, Shaping Sustainable AI" to demonstrate its cutting-edge technologies...

How to Survive and Thrive in the AI Era? ChinaAMC CEO Shares her thoughts

How to Survive and Thrive in the AI Era? ChinaAMC CEO Shares her thoughts

BEIJING, June 2, 2026 /PRNewswire/ -- Asset managers have to shift from individuals, experience-driven investment to platform-based, and industrialized framework to survive and thrive in the AI era, China Asset Management (ChinaAMC) CEO Li Yimei...

Axi Launches Trading Triumphs: The Stories Behind the Traders Who Earned Their Axi Select Funding

Axi Launches Trading Triumphs: The Stories Behind the Traders Who Earned Their Axi Select Funding

SYDNEY, June 2, 2026 /PRNewswire/ -- Most funded trading programmes focus on outcomes. Trading Triumphs focuses on the people behind them. Axi today announces the launch of Trading Triumphs, a content series from Axi Select dedicated to the real...

1 2 3 4 5 6 7 8 9 10 ... 4665
menu
menu